Researchers assessed long-term effectiveness and tolerability of brivaracetam in patients with focal epilepsy. According to this multicenter retrospective study, brivaracetam was effective and well-tolerated in a large population of patients with predominantly drug-resistant epilepsy. There were no unexpected adverse events (AEs) over 1 year. The most frequently reported AEs were somnolence, irritability and dizziness.
December 2, 2019
Three Anti-Seizure Drugs Equally Effective for Severe Form of Epilepsy
New findings published in the New England Journal of Medicine reveal that the three drugs, levetiracetam, fosphenytoin, and valproate, are equally safe and effective in treating patients with refractory status epilepticus.
November 26, 2019
Parent Reported Health Related Quality of Life (HRQoL) and Behavior in Young People with Epilepsy Before and Two Years After Epilepsy Surgery
The aim of this study was to compare parent-reported Health Related Quality of Life (HRQoL) and behavior of young people before (baseline) and two years after pediatric epilepsy surgery (follow-up).